noscript

News and Announcements

122% Returns: The Aussie Crypto Fund Outperforming Bitcoin

  • Published October 15, 2024 10:00AM UTC
  • Publisher Jade Miguel
  • Categories Capital Insights, Landing, Trending

In the ever-shifting world of cryptocurrency investments, one fund has made waves by consistently outperforming its peers. This fund has demonstrated a remarkable ability to navigate the volatility of the digital asset market while delivering impressive returns. By employing a combination of strategic risk management, selective investing, and benchmarking against Bitcoin, Merkle Tree Capital has positioned itself as a standout performer within the broader digital asset landscape.

Key Takeaways:

  • Strong Performance: MTC Digital Asset Fund achieved a 122% annual return in FY2024, outperforming its Bitcoin benchmark of 105%. It was the top-performing fund in Australia for FY23/24 based on Morningstar Data (as reported in the AFR).
  • Benchmark Strategy: The fund uses Bitcoin as a benchmark, aiming to add value beyond passive Bitcoin holding.
  • Risk Management: A multifactor risk overlay strategy is employed to navigate market volatility.
  • Selective Investing: The fund focuses on a small percentage of available tokens, prioritising high-potential projects.

YouTube player

Performance in Context

The MTC Digital Asset Fund’s 122% return in FY2024 is impressive, especially when compared to the broader crypto market. According to data from CoinGecko, the total cryptocurrency market cap grew by approximately 80% during the same period, indicating Merkle Tree Capital’s outperformance.

Ryan McMillin, Co-Founder and CIO of Merkle Tree Capital, notes, “We were the best performing fund in Australia last financial year, which was a great result for our investors, 122% versus our benchmark of 105%.”

Benchmark Strategy and Risk Management

Merkle Tree Capital’s use of Bitcoin as a benchmark sets a high bar for performance. “We’re also the only fund that was trying to beat Bitcoin. That Bitcoin benchmark is a large part of it,” McMillin explains.

The fund employs a sophisticated risk overlay strategy to navigate market volatility. This approach involves analysing multiple data sources, including technical analysis, on-chain data, sentiment indicators, and macroeconomic factors.

Selective Investment Approach

In a market flooded with tokens, Merkle Tree Capital takes a highly selective approach. “Millions of tokens… There’s a lot of junk out there in that number…We really want to focus on that top 1%, which is now really that top 0.01% is what we think is investable,” McMillin states.

Potential Risks and Challenges


While the MTC Digital Asset Fund’s strong returns are impressive, it is essential to recognise the inherent volatility of the cryptocurrency market. Crypto assets are known for their significant price swings, which can lead to sharp fluctuations in portfolio value. Investors need to understand that the crypto market’s extreme volatility can result in substantial losses, especially during downturns or market corrections.

In addition, the fund’s selective investment approach, which focuses on a very small percentage of available tokens, poses its own risks. Selective investing may lead to concentration risk, where the performance of the fund is heavily reliant on a few key assets. If any of these selected tokens underperform or face challenges, the fund could experience heightened volatility.

Despite this, the fund’s portfolio is concentrated on larger, more established tokens, with a focus on projects that are predominantly in the top 50 by market capitalisation. These projects typically have strong teams and solid metrics. 

Looking Ahead


The fund’s management is optimistic about future prospects, particularly regarding stablecoins and digital sovereign currencies. McMillin explains, “With blockchain technology through a crypto wallet, they can actually save and have a harder currency through US dollar stablecoins…at least on top of all the other really interesting narratives.”

For investors interested in exploring digital asset investments, Merkle Tree Capital’s approach offers valuable insights. However, thorough research and careful consideration of one’s risk tolerance are essential when investing in such a high-risk, high-reward environment. The unpredictable nature of the crypto market and the fund’s concentrated strategy mean investors must be prepared for potential downsides, even as they pursue outsized gains.

As the digital asset landscape continues to evolve, funds like MTC Digital Asset Fund provide a framework for navigating this complex market. While past performance is promising, the future of crypto investments remains an area of both opportunity and uncertainty.

Capital Insights
122% Returns: The Aussie Crypto Fund Outperforming Bitcoin

In the ever-shifting world of cryptocurrency investments, one fund has made waves by consistently outperforming its peers. This fund has demonstrated a remarkable ability to navigate the volatility of the digital asset market while delivering impressive returns. By employing a combination of strategic risk management, selective investing, and benchmarking against Bitcoin, Merkle Tree Capital has […]

Executive Interviews
Empowering Global Trade: TradeWindow’s Innovative Approach

Dive into an exclusive interview with AJ Smith, Founder & CEO of TradeWindow, as he unveils how TradeWindow is empowering businesses with digital tools to navigate the complexities of global trade. From reducing costs to improving real-time visibility and collaboration, TradeWindow is at the forefront of driving productivity and digital adoption in international trade. Gain […]

Executive Interviews
Novapep’s Pioneering Approach to Treating Inflammatory Bowel Diseases

Join Jay Hennock, CEO of Novapep, as he unveils the company’s mission to address unmet medical needs through peptide-based therapies. Novapep, an Australian/US biotech, has developed a patented peptide structure called biparediteTM as an oral inflammatory bowel disease therapy, which will be a cost effective first-in-class drug. Biparetide has been shown in animals to be […]

Join over 45,000+ sophisticated investors

Join Now